Key result
Microalbuminuria is linked to ~85% higher arterial stiffness and inflammation in new diabetes or hypertension.
Why the study?
Is microalbuminuria associated with arterial stiffness, carotid IMT, and vascular inflammation in patients with newly diagnosed type 2 diabetes or essential hypertension?
Cross-Sectional (n=446)
Yes
Is microalbuminuria associated with arterial stiffness, carotid IMT, and vascular inflammation in patients with newly diagnosed type 2 diabetes or essential hypertension?
Odds Ratio: 1.85 (95% CI 1.29–2.63)
p-value: p=<0.001
Microalbuminuria is independently associated with arterial stiffness and vascular inflammation, but not carotid IMT, in patients with newly diagnosed type 2 diabetes or essential hypertension.
Microalbuminuria's selective vascular associations should not change practice; hypothesis-generating, needs prospective validation.
The association between microalbuminuria (MAU) and the indices of macrovascular complication in patients with newly diagnosed type 2 diabetes (D) or essential hypertension (H) was evaluated. Total 446 patients were classified into four groups according to the urinary albumin-to-creatinine ratio: MAU-D (n = 104), normoalbuminuria (NAU)-D (n = 114), MAU-H (n = 116), and NAU-H (n = 112). The indices of macrovascular complication including arterial stiffness evaluated by pulse-wave-velocity (PWV), carotid intima-media thickness (IMT), and vascular inflammation marked by high-sensitivity C-reactive protein (hsCRP) were assessed. PWV, IMT, and hsCRP were higher in patients with MAU than in those with NAU in both diabetes and hypertension groups. In both MAU-D and MAU-H groups, PWV and hsCRP levels were positively correlated with MAU level (MAU-D: r = 0.47, 0.41, MAU-H: r = 0.36, 0.62, respectively, P < 0.05). Additionally, PWV and hsCRP were independent factors predicting MAU (diabetes group: OR 1.85, 1.54, hypertension group: OR 1.38, 1.51, respectively, P < 0.001), but not IMT. MAU is independently associated with arterial stiffness and vascular inflammation but not with IMT in patients with newly diagnosed type 2 diabetes or essential hypertension, which emphasizes the importance of proactive clinical investigations for atherosclerotic complications in patients with MAU, even in newly diagnosed diabetes or hypertension.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2013) conducted a cross-sectional in Newly diagnosed type 2 diabetes or essential hypertension (n=446). Microalbuminuria vs. Normoalbuminuria was evaluated on Prediction of microalbuminuria by pulse-wave velocity (PWV) in newly diagnosed diabetes (OR 1.85, 95% CI 1.29-2.63, p=<0.001). Microalbuminuria is independently associated with increased arterial stiffness and vascular inflammation, but not with carotid intima-media thickness, in patients with newly diagnosed type 2 diabetes or essential hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: